Norgestimate increases pituitary and hypothalamic concentrations of immunoreactive beta-endorphin

Contraception. 1989 Nov;40(5):605-13. doi: 10.1016/0010-7824(89)90132-7.

Abstract

Progesterone is a potent hormone acting on the female reproductive tract and influencing a series of other functions. Recent studies revealed a correlation between progesterone and brain neurotransmitters and neuropeptides. Our study evaluated the possible effect of norgestimate, a new progestin, on hypothalamic and pituitary beta-endorphin (B-EP) concentration in castrated female rats. Ovariectomy was performed under ethyl ether anesthesia. Treatment was started 3 weeks after surgery. Norgestimate, estradiol benzoate or norgestimate plus estradiol benzoate were administered. The two steroids were dissolved in sesame oil and injected (s.c.) every day for 2 weeks. Pituitary and hypothalamus B-EP concentrations were measured by radioimmunoassay. Our studies showed that norgestimate increases the pituitary and hypothalamic B-EP concentration in female rats, reaching values higher than controls and estrogen-treated rats. Because B-EP has an important role in reproductive function, both modulating gonadotropin secretion and sexual behavior, the present results lead to the hypothesis that norgestimate affecting B-EP concentrations may influence central functions.

MeSH terms

  • Animals
  • Estradiol / analogs & derivatives
  • Estradiol / pharmacology
  • Female
  • Hypothalamus / metabolism*
  • Norgestrel / analogs & derivatives*
  • Norgestrel / pharmacology
  • Pituitary Gland / metabolism*
  • Radioimmunoassay
  • Rats
  • Rats, Inbred Strains
  • beta-Endorphin / immunology
  • beta-Endorphin / metabolism*

Substances

  • Norgestrel
  • Estradiol
  • beta-Endorphin
  • estradiol-17 beta-benzoate
  • norgestimate